On the public citation graph

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

0 signed · 533 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1006/bbrc.1997.6978openalex-snapshot
NACP, a Synaptic Protein Involved in Alzheimer's Disease, Is Differentially Regulated during Megakaryocyte Differentiation
inferredcites →https://doi.org/10.1007/s10059-000-0065-xopenalex-snapshot
Expression Patterns of α-Synuclein in Human Hematopoietic Cells and in Drosophila at Different Developmental Stages
inferredcites →https://doi.org/10.1016/0009-8981(90)90075-4openalex-snapshot
A new, rapid, one-step method for the isolation of platelets from human blood
inferredcites →https://doi.org/10.1016/j.neulet.2005.02.030openalex-snapshot
Skin and platelet α-synuclein as peripheral biomarkers of Parkinson's disease
inferredcites →https://doi.org/10.1021/bi961799nopenalex-snapshot
NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded
inferredcites →https://doi.org/10.1038/42166openalex-snapshot
α-Synuclein in Lewy bodies
inferredcites →https://doi.org/10.1046/j.1523-1755.1999.0550031063.xopenalex-snapshot
Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome
inferredcites →https://doi.org/10.1074/jbc.m600933200openalex-snapshot
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
inferredcites →https://doi.org/10.1096/fj.03-0098fjeopenalex-snapshot
α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
inferredcites →https://doi.org/10.1111/j.1471-4159.1990.tb05792.xopenalex-snapshot
Purification and Characterization of a Novel Brain‐Specific 14‐kDa Protein
inferredcites →https://doi.org/10.1126/science.1090278openalex-snapshot
α-Synuclein Locus Triplication Causes Parkinson's Disease
inferredcites →https://doi.org/10.1126/science.276.5321.2045openalex-snapshot
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
inferredcites →https://doi.org/10.1152/jappl.2001.91.3.1084openalex-snapshot
Effect of mechanical deformation of neutrophils on their CD18/ICAM-1-dependent adhesion
inferredcites →https://doi.org/10.1182/blood-2005-11-007799openalex-snapshot
In-depth analysis of the membrane and cytosolic proteome of red blood cells
inferredcites →https://doi.org/10.1186/1471-2202-2-11openalex-snapshot
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice
inferredcites →https://doi.org/10.1212/01.wnl.0000127517.33208.f4openalex-snapshot
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
inferredcites →https://doi.org/10.1523/jneurosci.08-08-02804.1988openalex-snapshot
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
inferredcites →https://doi.org/10.3233/jad-2002-4406openalex-snapshot
Platelet α- and γ-synucleins in Parkinson's disease and normal control subjects

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4663946openalex-extracted
Framework for Measuring Protein Cargo in Extracellular Vesicles: Application to Assessing Neurodegenerative Disease Biomarkers
inferred← citeshttps://doi.org/10.1001/archneurol.2010.279openalex-snapshot
SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
inferred← citeshttps://doi.org/10.1002/2211-5463.12844openalex-snapshot
Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuIC
inferred← citeshttps://doi.org/10.1002/9781444318579.ch4openalex-snapshot
Biomarkers and Surrogate Markers in Drug Development
inferred← citeshttps://doi.org/10.1002/acn3.50944openalex-snapshot
α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
inferred← citeshttps://doi.org/10.1002/acn3.756openalex-snapshot
Plasma α ‐synuclein levels are increased in patients with obstructive sleep apnea syndrome
inferred← citeshttps://doi.org/10.1002/advs.77643openalex-snapshot
Probing the Energy Landscape of α‐Synuclein Amyloid Fibril Formation by Systematic K‐to‐Q Mutagenesis
inferred← citeshttps://doi.org/10.1002/ajh.21932openalex-snapshot
Alpha‐ and beta‐synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia
inferred← citeshttps://doi.org/10.1002/cbic.202400253openalex-snapshot
Synthesis and Semi‐Synthesis of Alpha‐Synuclein: Insight into the Chemical Complexity of Synucleinopathies
inferred← citeshttps://doi.org/10.1002/chem.202300649openalex-snapshot
Chemical Synthesis of Alpha‐Synuclein Proteins via Solid‐Phase Peptide Synthesis and Native Chemical Ligation
inferred← citeshttps://doi.org/10.1002/glia.23645openalex-snapshot
GlialHMOX1expression promotes central and peripheral α‐synuclein dysregulation and pathogenicity in parkinsonian mice
inferred← citeshttps://doi.org/10.1002/jcph.6103openalex-snapshot
Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti‐α‐Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults
inferred← citeshttps://doi.org/10.1002/mds.111openalex-snapshot
α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
inferred← citeshttps://doi.org/10.1002/mds.22928openalex-snapshot
Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
inferred← citeshttps://doi.org/10.1002/mds.25688openalex-snapshot
Increase of the plasma α‐synuclein levels in patients with multiple system atrophy
inferred← citeshttps://doi.org/10.1002/mds.26479openalex-snapshot
Synaptic failure and α‐synuclein
inferred← citeshttps://doi.org/10.1002/mds.26481openalex-snapshot
Development of P assive I mmunotherapies for S ynucleinopathies
inferred← citeshttps://doi.org/10.1002/mds.26754openalex-snapshot
Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
inferred← citeshttps://doi.org/10.1002/mds.27090openalex-snapshot
A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations
inferred← citeshttps://doi.org/10.1002/mds.27232openalex-snapshot
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
inferred← citeshttps://doi.org/10.1002/mds.28030openalex-snapshot
Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy
inferred← citeshttps://doi.org/10.1002/mds.28941openalex-snapshot
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
inferred← citeshttps://doi.org/10.1002/mds.29497openalex-snapshot
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1002/mds.29583openalex-snapshot
Erythrocytic α‐Synuclein Species as Biomarkers for Isolated Rapid Eye Movement Sleep Behavior Disorder
inferred← citeshttps://doi.org/10.1002/med.22091openalex-snapshot
α‐Synuclein in Parkinson's Disease: From Bench to Bedside
inferred← citeshttps://doi.org/10.1002/trc2.12124openalex-snapshot
Apolipoprotein E4–driven effects on inflammatory and neurotrophic factors in peripheral extracellular vesicles from cognitively impaired, no dementia participants who converted to Alzheimer's disease
inferred← citeshttps://doi.org/10.1007/978-1-0716-4083-8_8openalex-snapshot
Translational Value of CSF and Serum Markers
inferred← citeshttps://doi.org/10.1007/978-1-4939-3560-4_11openalex-snapshot
Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4939-3560-4_14openalex-snapshot
Alpha-Synuclein as a Diagnostic Biomarker for Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4939-9124-2_16openalex-snapshot
Detection of α-Synuclein in Biological Samples Using Mass Spectrometry
inferred← citeshttps://doi.org/10.1007/978-3-031-66513-4_6openalex-snapshot
Skin Biomarkers of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-3-031-68237-7_44openalex-snapshot
Biomarkers for Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-3-031-80849-4_3openalex-snapshot
Fluid and Imaging Markers of Synuclein Pathology
inferred← citeshttps://doi.org/10.1007/978-3-031-96352-0_25openalex-snapshot
Platelets in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-3-032-18296-8_16openalex-snapshot
Models of Synucleinopathies
inferred← citeshttps://doi.org/10.1007/978-3-319-57193-5_3openalex-snapshot
Parkinson’s Disease: Basic Pathomechanisms and a Clinical Overview
inferred← citeshttps://doi.org/10.1007/978-3-642-35491-5_8openalex-snapshot
Accumulating Evidence Suggests that Parkinson’s Disease Is a Prion-Like Disorder
inferred← citeshttps://doi.org/10.1007/978-4-431-55948-1_13openalex-snapshot
Alpha-Synuclein in Cerebrospinal Fluid
inferred← citeshttps://doi.org/10.1007/978-94-007-5416-4_6openalex-snapshot
α-Synuclein Aggregation and Modulating Factors
inferred← citeshttps://doi.org/10.1007/978-94-007-5866-7_6openalex-snapshot
The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases
inferred← citeshttps://doi.org/10.1007/978-981-16-6703-9_12openalex-snapshot
Biomarkers: Potential Perspectives in Detection, Diagnosis, and Prognosis of Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/978-981-97-7067-0_14openalex-snapshot
Neurodegenerative Disorder and Fine Particulate Matter
inferred← citeshttps://doi.org/10.1007/bf03256398openalex-snapshot
Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/s00018-012-1198-8openalex-snapshot
Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway
inferred← citeshttps://doi.org/10.1007/s00018-025-05985-2openalex-snapshot
Revisiting the alpha-synuclein paradox in melanoma-Parkinson’s disease connection: more than a tale of two cell fates
inferred← citeshttps://doi.org/10.1007/s00335-012-9393-3openalex-snapshot
QTLs for murine red blood cell parameters in LG/J and SM/J F2 and advanced intercross lines
inferred← citeshttps://doi.org/10.1007/s00401-014-1314-yopenalex-snapshot
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00401-018-1832-0openalex-snapshot
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
inferred← citeshttps://doi.org/10.1007/s00401-025-02909-zopenalex-snapshot
Subclinical detection of misfolded alpha-synuclein in the blood of M83 mice
inferred← citeshttps://doi.org/10.1007/s00401-026-03057-8openalex-snapshot
Complement dysregulation during the early phases of synucleinopathy
inferred← citeshttps://doi.org/10.1007/s00415-011-6209-4openalex-snapshot
Variant in the 3′ region of SNCA associated with Parkinson’s disease and serum α-synuclein levels
inferred← citeshttps://doi.org/10.1007/s00415-018-8847-2openalex-snapshot
Alpha-synuclein is present in dental calculus but not altered in Parkinson’s disease patients in comparison to controls
inferred← citeshttps://doi.org/10.1007/s00415-020-09781-9openalex-snapshot
Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s00415-020-10162-5openalex-snapshot
Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field
inferred← citeshttps://doi.org/10.1007/s00415-022-11267-9openalex-snapshot
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00415-023-11893-xopenalex-snapshot
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s00415-024-12871-7openalex-snapshot
Plasma alpha-synuclein predicts cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s00604-023-06158-3openalex-snapshot
Lab-made disposable screen-printed electrochemical sensors and immunosensors modified with Pd nanoparticles for Parkinson’s disease diagnostics
inferred← citeshttps://doi.org/10.1007/s00702-013-0972-6openalex-snapshot
Gender differences in Parkinson’s disease: focus on plasma alpha-synuclein
inferred← citeshttps://doi.org/10.1007/s00702-019-02062-4openalex-snapshot
Salivary alpha-synuclein as a biomarker for Parkinson’s disease: a systematic review
inferred← citeshttps://doi.org/10.1007/s00702-022-02498-1openalex-snapshot
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
inferred← citeshttps://doi.org/10.1007/s10048-014-0430-0openalex-snapshot
Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy
inferred← citeshttps://doi.org/10.1007/s10072-016-2485-1openalex-snapshot
A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s10072-019-03738-1openalex-snapshot
Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10571-024-01518-wopenalex-snapshot
The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential
inferred← citeshttps://doi.org/10.1007/s10571-024-01523-zopenalex-snapshot
Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related Diseases
inferred← citeshttps://doi.org/10.1007/s10571-025-01560-2openalex-snapshot
Exploring α-Syn’s Functions Through Ablation Models: Physiological and Pathological Implications
inferred← citeshttps://doi.org/10.1007/s11010-024-05190-yopenalex-snapshot
Advancing Parkinson’s diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples
inferred← citeshttps://doi.org/10.1007/s11064-022-03586-0openalex-snapshot
Distribution of α-Synuclein Aggregation in the Peripheral Tissues
inferred← citeshttps://doi.org/10.1007/s11239-021-02607-zopenalex-snapshot
Initial assessment of α-synuclein structure in platelets
inferred← citeshttps://doi.org/10.1007/s12017-016-8435-5openalex-snapshot
Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways
inferred← citeshttps://doi.org/10.1007/s12031-016-0829-1openalex-snapshot
Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/s12031-020-01498-8openalex-snapshot
alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
inferred← citeshttps://doi.org/10.1007/s12031-024-02278-4openalex-snapshot
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise
inferred← citeshttps://doi.org/10.1007/s12035-012-8325-2openalex-snapshot
Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
inferred← citeshttps://doi.org/10.1007/s12035-017-0479-5openalex-snapshot
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
inferred← citeshttps://doi.org/10.1007/s12035-017-0523-5openalex-snapshot
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects
inferred← citeshttps://doi.org/10.1007/s12035-019-1531-4openalex-snapshot
Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-021-02500-zopenalex-snapshot
Pursuing Multiple Biomarkers for Early Idiopathic Parkinson’s Disease Diagnosis
inferred← citeshttps://doi.org/10.1007/s12035-021-02604-6openalex-snapshot
Strong Predictive Algorithm of Pathogenesis-Based Biomarkers Improves Parkinson’s Disease Diagnosis
inferred← citeshttps://doi.org/10.1007/s12035-022-03139-0openalex-snapshot
Endoplasmic Reticulum Stress-Regulated Chaperones as a Serum Biomarker Panel for Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12035-024-04561-2openalex-snapshot
Complement Receptor 1 Is a Potential Extracerebral Factor Promoting α-Synuclein Pathology
inferred← citeshttps://doi.org/10.1007/s12079-017-0402-xopenalex-snapshot
Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells
inferred← citeshttps://doi.org/10.1007/s12185-018-2457-8openalex-snapshot
The localization of α-synuclein in the process of differentiation of human erythroid cells
inferred← citeshttps://doi.org/10.1007/s12264-016-0092-zopenalex-snapshot
Exosomes in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s12264-025-01516-yopenalex-snapshot
α-Synuclein Pathology from Kidney to Brain in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1007/s13167-010-0036-zopenalex-snapshot
Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy
inferred← citeshttps://doi.org/10.1007/s13273-020-00104-7openalex-snapshot
Decreased plasma α-synuclein in idiopathic Parkinson’s disease patients after adjusting hemolysis factor
inferred← citeshttps://doi.org/10.1007/s13311-020-00842-5openalex-snapshot
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease
inferred← citeshttps://doi.org/10.1007/s13311-022-01288-7openalex-snapshot
Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
inferred← citeshttps://doi.org/10.1007/s13311-023-01365-5openalex-snapshot
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans
inferred← citeshttps://doi.org/10.1007/s13760-023-02452-2openalex-snapshot
Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson’s disease
inferred← citeshttps://doi.org/10.1007/s40120-018-0122-zopenalex-snapshot
Emerging Immunotherapies for Parkinson Disease
inferred← citeshttps://doi.org/10.1007/s40120-019-00166-3openalex-snapshot
Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment
inferred← citeshttps://doi.org/10.1007/s40265-019-01104-1openalex-snapshot
Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-12-800141-7.00005-xopenalex-snapshot
CSF in Alzheimer's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-802173-6.00021-6openalex-snapshot
Fluid Biomarkers and Diagnostics
inferred← citeshttps://doi.org/10.1016/b978-0-12-804279-3.00006-xopenalex-snapshot
Cerebrospinal fluid in the dementias
inferred← citeshttps://doi.org/10.1016/b978-0-12-811304-2.00008-0openalex-snapshot
Prion-Like Propagation in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-816347-4.00004-0openalex-snapshot
Neurochemical Aspects of Lewy Body Dementia
inferred← citeshttps://doi.org/10.1016/b978-0-12-819410-2.00008-4openalex-snapshot
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-819603-8.00007-9openalex-snapshot
Insulin resistance and Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/bs.acc.2019.12.001openalex-snapshot
New markers in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/bs.acc.2020.08.007openalex-snapshot
Synuclein in neurodegeneration
inferred← citeshttps://doi.org/10.1016/bs.acc.2022.09.006openalex-snapshot
Fluid biomarkers in Alzheimer's disease
inferred← citeshttps://doi.org/10.1016/bs.acc.2024.11.001openalex-snapshot
Emerging biomarkers in Gaucher disease
inferred← citeshttps://doi.org/10.1016/bs.irn.2026.02.006openalex-snapshot
Blood-based biomarkers in Alzheimer’s and Parkinson’s disease: From molecular pathology to therapeutic potential
inferred← citeshttps://doi.org/10.1016/bs.pbr.2020.01.003openalex-snapshot
Prodromal PD: A new nosological entity
inferred← citeshttps://doi.org/10.1016/j.aca.2025.344497openalex-snapshot
In-capillary enzymatic digestion beyond trypsin for the sensitive targeted bottom-up analysis of protein biomarkers by capillary electrophoresis-mass spectrometry
inferred← citeshttps://doi.org/10.1016/j.arr.2025.102658openalex-snapshot
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.bbadis.2014.06.024openalex-snapshot
Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins
inferred← citeshttps://doi.org/10.1016/j.bbi.2020.01.018openalex-snapshot
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.bbr.2026.116120openalex-snapshot
Parkinson’s disease biomarkers: bridging the gap between diagnosis and treatment
inferred← citeshttps://doi.org/10.1016/j.bcmd.2018.09.001openalex-snapshot
Ultrastructural changes in peripheral blood leukocytes in α-synuclein knockout mice
inferred← citeshttps://doi.org/10.1016/j.bcp.2017.01.017openalex-snapshot
Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.biochi.2021.09.012openalex-snapshot
Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2025.111516openalex-snapshot
Inhibition of DYRK1A can alleviate MPTP/MPP+-induced neuronal apoptosis and mitochondrial damage
inferred← citeshttps://doi.org/10.1016/j.cell.2022.05.008openalex-snapshot
The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.110090openalex-snapshot
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2024.105377openalex-snapshot
Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
inferred← citeshttps://doi.org/10.1016/j.conb.2019.11.019openalex-snapshot
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
inferred← citeshttps://doi.org/10.1016/j.dmd.2026.100304openalex-snapshot
Peptide-mediated delivery of an α-synuclein–targeting antisense oligonucleotide: Pharmacokinetics, safety, and central nervous system efficacy in a synucleinopathy model
inferred← citeshttps://doi.org/10.1016/j.dscb.2025.100297openalex-snapshot
Early diagnosis of Parkinson's disease pathogenesis using biofluidic biomarkers with a focus on α-synuclein
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.179194openalex-snapshot
Terbutaline selectively reduces non-fibrillar α-synuclein aggregates and oxidative stress without affecting liquid–liquid phase separation or fibrillogenesis
inferred← citeshttps://doi.org/10.1016/j.envres.2014.10.014openalex-snapshot
Blood α-synuclein in agricultural pesticide handlers in central Washington State
inferred← citeshttps://doi.org/10.1016/j.exger.2018.12.008openalex-snapshot
Alpha-synuclein is highly prone to distribution in the hippocampus and midbrain in tree shrews, and its fibrils seed Lewy body-like pathology in primary neurons
inferred← citeshttps://doi.org/10.1016/j.exphem.2021.01.001openalex-snapshot
Erythroid enucleation: a gateway into a “bloody” world
inferred← citeshttps://doi.org/10.1016/j.expneurol.2008.06.004openalex-snapshot
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.expneurol.2017.10.003openalex-snapshot
Therapeutic approaches to target alpha-synuclein pathology
inferred← citeshttps://doi.org/10.1016/j.expneurol.2025.115403openalex-snapshot
Research progress on platelet factor 4 in improving cognition
inferred← citeshttps://doi.org/10.1016/j.febslet.2013.02.049openalex-snapshot
Exploring the accessible conformations of N‐terminal acetylated α‐synuclein
inferred← citeshttps://doi.org/10.1016/j.gendis.2019.12.001openalex-snapshot
Extracellular vesicles in neurodegenerative diseases: Insights and new perspectives
inferred← citeshttps://doi.org/10.1016/j.heliyon.2018.e00513openalex-snapshot
CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology
inferred← citeshttps://doi.org/10.1016/j.heliyon.2019.e02590openalex-snapshot
Alpha synuclein in hematopoiesis and immunity
inferred← citeshttps://doi.org/10.1016/j.imbio.2014.07.014openalex-snapshot
Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.jalz.2018.05.008openalex-snapshot
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
inferred← citeshttps://doi.org/10.1016/j.jare.2023.09.009openalex-snapshot
Calcium influx: An essential process by which α-Synuclein regulates morphology of erythrocytes
inferred← citeshttps://doi.org/10.1016/j.jare.2026.05.025openalex-snapshot
Spatial transcriptomics links hippocampal synaptic remodeling to microglial phagocytosis in synucleinopathy
inferred← citeshttps://doi.org/10.1016/j.jim.2015.08.003openalex-snapshot
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid
inferred← citeshttps://doi.org/10.1016/j.jns.2013.11.033openalex-snapshot
Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.jns.2017.09.039openalex-snapshot
CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes
inferred← citeshttps://doi.org/10.1016/j.jns.2018.10.002openalex-snapshot
SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.mcn.2018.04.006openalex-snapshot
Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
inferred← citeshttps://doi.org/10.1016/j.mcn.2022.103746openalex-snapshot
The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.molmed.2022.05.008openalex-snapshot
Staging of Alzheimer’s disease: past, present, and future perspectives
inferred← citeshttps://doi.org/10.1016/j.nbd.2011.08.003openalex-snapshot
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1016/j.nbd.2018.11.002openalex-snapshot
Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2021.105512openalex-snapshot
Alternative platelet activation pathways and their role in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105625openalex-snapshot
Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?
inferred← citeshttps://doi.org/10.1016/j.nbd.2022.105654openalex-snapshot
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2023.105997openalex-snapshot
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up
inferred← citeshttps://doi.org/10.1016/j.neuint.2010.04.011openalex-snapshot
Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: A link to autonomic dysfunction in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.neulet.2008.11.015openalex-snapshot
Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
inferred← citeshttps://doi.org/10.1016/j.neulet.2010.06.009openalex-snapshot
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.neulet.2012.08.069openalex-snapshot
Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging
inferred← citeshttps://doi.org/10.1016/j.neulet.2015.05.030openalex-snapshot
Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.neulet.2017.11.012openalex-snapshot
Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.neulet.2020.135274openalex-snapshot
Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs
inferred← citeshttps://doi.org/10.1016/j.neulet.2021.135901openalex-snapshot
α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson’s disease in Mexican Mestizos
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2010.06.023openalex-snapshot
Late-life hemoglobin and the incidence of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.neurobiolaging.2014.10.042openalex-snapshot
The link between the SNCA gene and parkinsonism
inferred← citeshttps://doi.org/10.1016/j.neuron.2013.09.004openalex-snapshot
The Function of α-Synuclein
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2016.02.042openalex-snapshot
Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2019.05.015openalex-snapshot
Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2020.01.037openalex-snapshot
Elevated Serum α-Synuclein Levels in Huntington’s Disease Patients
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2022.11.017openalex-snapshot
An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2025.10.025openalex-snapshot
Decreased DNA methyltransferase 1 level in blood cells in Parkinson’s disease
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2026.04.007openalex-snapshot
Neuronal vulnerability in Parkinson’s disease: insights from murine α-synuclein pathology models
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2018.09.012openalex-snapshot
Alpha-synuclein in erythrocyte membrane of patients with multiple system atrophy: A pilot study
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2018.11.021openalex-snapshot
Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2020.03.014openalex-snapshot
Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2022.06.001openalex-snapshot
Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2022.09.011openalex-snapshot
Erythrocytic alpha-synuclein in early Parkinson's disease: A 3-year longitudinal study
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2025.107321openalex-snapshot
Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2026.108416openalex-snapshot
Plasma cfDNA hypermethylation at SNCA intron 1 as a potential blood-based epigenetic signal in Parkinson's disease and multiple system atrophy
inferred← citeshttps://doi.org/10.1016/j.pjnns.2017.11.009openalex-snapshot
The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.pneurobio.2011.09.002openalex-snapshot
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
inferred← citeshttps://doi.org/10.1016/j.procbio.2021.10.015openalex-snapshot
Recent advances in nanosensors development for biomarker alpha-synuclein protein detection
inferred← citeshttps://doi.org/10.1016/j.redox.2023.102743openalex-snapshot
Oxime blot: A novel method for reliable and sensitive detection of carbonylated proteins in diverse biological systems
inferred← citeshttps://doi.org/10.1016/j.sbi.2017.09.004openalex-snapshot
Order and disorder in the physiological membrane binding of α-synuclein
inferred← citeshttps://doi.org/10.1016/j.thromres.2010.01.009openalex-snapshot
Mice with deleted multimerin 1 and α-synuclein genes have impaired platelet adhesion and impaired thrombus formation that is corrected by multimerin 1
inferred← citeshttps://doi.org/10.1016/j.tibs.2018.11.005openalex-snapshot
The Cellular Environment Affects Monomeric α-Synuclein Structure
inferred← citeshttps://doi.org/10.1016/j.tins.2024.06.005openalex-snapshot
Evolving insights into erythrocytes in synucleinopathies
inferred← citeshttps://doi.org/10.1016/j.ymgme.2010.08.004openalex-snapshot
Gaucher disease and parkinsonism, a molecular link theory
inferred← citeshttps://doi.org/10.1016/j.ymgme.2019.10.006openalex-snapshot
GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies
inferred← citeshttps://doi.org/10.1016/s1474-4422(19)30024-9openalex-snapshot
CSF and blood biomarkers for Parkinson's disease
inferred← citeshttps://doi.org/10.1016/s1474-4422(25)00194-2openalex-snapshot
α-synuclein biomarker assays: bridging research and patient care
inferred← citeshttps://doi.org/10.1021/acs.analchem.9b04802openalex-snapshot
On-line Aptamer Affinity Solid-Phase Extraction Capillary Electrophoresis-Mass Spectrometry for the Analysis of Blood α-Synuclein
inferred← citeshttps://doi.org/10.1021/acs.jpcb.2c08326openalex-snapshot
Quantitative Seed Amplification Assay: A Proof-of-Principle Study
inferred← citeshttps://doi.org/10.1021/acs.jpcb.9b02381openalex-snapshot
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids
inferred← citeshttps://doi.org/10.1021/acs.jproteome.6c00032openalex-snapshot
Development and Validation of a Streamlined Workflow for Proteomic Analysis of Proteins and Post-translational Modifications from Dried Blood
inferred← citeshttps://doi.org/10.1021/acs.jproteome.7b00025openalex-snapshot
Quantitative Analysis of Human Red Blood Cell Proteome
inferred← citeshttps://doi.org/10.1021/acs.jproteome.8b00982openalex-snapshot
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1021/acschemneuro.4c00263openalex-snapshot
β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1021/acschemneuro.8b00288openalex-snapshot
Alpha-Synuclein Nitration and Its Implications in Parkinson’s Disease
inferred← citeshttps://doi.org/10.1021/acsnano.3c08623openalex-snapshot
Deep Learning-Assisted Single-Molecule Detection of Protein Post-translational Modifications with a Biological Nanopore
inferred← citeshttps://doi.org/10.1021/bi501188aopenalex-snapshot
Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity
inferred← citeshttps://doi.org/10.1021/ja312415qopenalex-snapshot
Site-Specific Interaction between α-Synuclein and Membranes Probed by NMR-Observed Methionine Oxidation Rates
inferred← citeshttps://doi.org/10.1038/cddis.2012.94openalex-snapshot
Alpha-synuclein: from secretion to dysfunction and death
inferred← citeshttps://doi.org/10.1038/nrneurol.2009.135openalex-snapshot
Biological fluid biomarkers in neurodegenerative parkinsonism
showing the first 200 of 515 · page through all 515
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.